Chesapeake Utilities Corp. (NYSE: CPK) has reported E.P.S. of $1.60 for its fourth fiscal quarter (ending December 31) versus $1.26 for the same period a year ago — an increase of 27%. For the latest […]
For its fourth fiscal quarter (ending December 31), Chemed Corp (NYSE: CHE) has reported a 2% increase in E.P.S. from $5.96 a year ago to $6.08 in the current quarter. E.P.S. were $20.10 for the […]
Ceva Inc (NASDAQ: CEVA) stock closed at $38.44 on 2/26/25 after a major increase of 18.3%. Moreover, this advance was accompanied by exceptionally high trading volume at 375% of normal. Relative to the market the […]
Bloomin’ Brands Inc (NASDAQ: BLMN) has reported E.P.S. of $0.13 for its fourth fiscal quarter (ending December 31) versus $0.50 for the same period a year ago — a decline of -74%. For the latest […]
For its fourth fiscal quarter (ending December 31), Amedisys Inc (NASDAQ: AMED) has reported a -205% decline in E.P.S. from $0.59 a year ago to $-0.62 in the current quarter. E.P.S. were $1.32 for the […]
Sarepta Therapeutics Inc (NASDAQ: SRPT) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.65 versus $0.49 for the same period a year ago — an increase of 237%. For the latest […]
OraSure Technologies Inc (NASDAQ: OSUR) stock closed at $3.06 on 2/26/25 after a major decline of -23.5%. Moreover, trading volume in this decline was exceptionally high at 518% of normal. The stock has declined -22.7% […]
Masimo Corp (NASDAQ: MASI) stock closed at $190.47 on 2/26/25 after a major increase of 12.3%. Moreover, trading volume in this advance was exceptionally high at 304% of normal. The stock has risen 5.6% during […]
HEICO Corp (NYSE: HEI) has reported E.P.S. of $1.21 for its first fiscal quarter (ending January 31) versus $0.83 for the same period a year ago — an increase of 46%. For the latest four […]
Corcept Therapeutics Inc (NASDAQ: CORT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.29 versus $0.30 for the same period a year ago — a decline of -3%. For the latest […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research